DigitalJournal.com Research and Development Forecast of China Heparin Industry to 2017 mainly analyzes the global and domestic market status quo of heparin industry, development conditions of heparin upstream and downstream industry, the supply and demand of major ... and more »
Pharmacy Times Heparin -induced thrombocytopenia (HIT) is a well-described adverse drug reaction that can occur with heparin administration and lead to devastating thromboembolic complications.1 HIT is the most frequent drug-induced type of thrombocytopenia and is ...
The Herald | HeraldOnline.com (press release) The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be ...
Healio April 2, 2014. WASHINGTON — Results from a single-center study of patients with STEMI undergoing primary PCI showed that heparin was associated with reduced rates of MACE and stent thrombosis compared with bivalirudin at 28 days. Rod Stables, MD ...
TCTMD WASHINGTON, DC—In addition to causing a stir by demonstrating worse outcomes with bivalirudin than heparin in patients with ST-segment elevation myocardial infar...
Medscape The single-center randomized trial of unfractionated heparin vs bivalirudin (Angiomax, the Medicines Company) (with bailout GPIIb/IIIa inhibitors) in STEMI patients surprised attendees on the last day of the meeting by showing a significantly lower ...
海普瑞4月11日发布公告称，公司重大资产购买美国SPL Acquisition Corp.的资产过户手续办理完毕。至此，SPL100%的股权已登记在Hepalink USA Inc.名下，成为海普瑞在全球肝素原料药供应体系的一部分。本次成功收购SPL是海普瑞全球战略迈出的重要一步，也是海普瑞在2012年投资加拿大上市公司Prometic Life Science Inc.以来，进一步完善和强化公司在肝素原料药相关领域布局的关键之举。
